MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2024 and provided a corporate ...
Company announcement - No. 5 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 - Zealand Pharma A/S ("Zealand") (NA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback